GW Pharmaceuticals PLC EBITDA 2016-2021 | GWPH
GW Pharmaceuticals PLC ebitda from 2016 to 2021. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| GW Pharmaceuticals PLC Annual EBITDA (Millions of US $) |
|
|---|---|
| 2020 | $-39 |
| 2019 | $-109 |
| 2018 | $ |
| 2018 | $-280 |
| 2017 | $-159 |
| 2016 | $-118 |
| 2015 | $-84 |
| 2014 | $ |
| 2012 | $ |
| GW Pharmaceuticals PLC Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2021-03-31 | $-17 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-9 |
| 2020-06-30 | $-6 |
| 2020-03-31 | $-5 |
| 2019-12-31 | $-18 |
| 2019-09-30 | $-15 |
| 2019-06-30 | $-27 |
| 2019-03-31 | $-49 |
| 2018-12-31 | |
| 2018-09-30 | $-78 |
| 2018-06-30 | $-79 |
| 2018-03-31 | $-66 |
| 2017-12-31 | $8 |
| 2017-06-30 | $-59 |
| 2017-03-31 | $-46 |
| 2016-12-31 | $3 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-30 |
| 2015-12-31 | $5 |
